Dataset
Data used in the preparation of this article were obtained from the ADNI. The ADNI was launched in 2003 as a public–private partnership, led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been to test whether MRI, positron emission tomography, other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of MCI and AD22,23. All relevant tests and methods were performed in accordance with relevant guidelines and regulations, and this study was approved by the ADNI Publications Committee.
1.5 T…
Continue Reading
News Source: www.nature.com